Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD40 is a type I transmembrane protein and a member of the tumor necrosis factor receptor (TNFR) superfamily. It plays a central role in immune regulation, particularly in the activation and function of antigen-presenting cells (APCs) such as B cells, dendritic cells, and macrophages. Interaction with its ligand CD154 regulates critical processes like antibody class switching and germinal center formation. Defects in CD40 or CD154 result in severe immunodeficiency syndromes.
Engagement of CD40 with its ligand CD154 triggers key signaling pathways essential for immune responses, modulating B cell, macrophage, and dendritic cell function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cluster of Differentiation 40 (CD40).